Alimera, pSivida win UK OK for eye treatment
This article was originally published in Scrip
Executive Summary
US biotech Alimera Sciences and its partner pSivida on 7 May celebrated the UK approval of Iluvien (fluocinolone acetonide intravitreal insert) as a treatment of vision impairment associated with chronic diabetic macular oedema (DMO) considered insufficiently responsive to available therapies.